Phase Ib/IIa Clinical Study of ApTOLL for the Treatment of Acute Ischemic Stroke

NCT04734548 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

151

Enrollment

INDUSTRY

Sponsor class

Conditions

Stroke
Acute Stroke
Ischemic Stroke

Interventions

DRUG: ApTOLL
OTHER: Placebo

Sponsor

aptaTargets S.L.

Collaborators

[object Object]
[object Object]